Palivizumab Injection — FDA Drug Shortage

No longer listed by FDA — Swedish Orphan Biovitrum AB

The FDA lists a drug shortage record for Palivizumab Injection (injection) from Swedish Orphan Biovitrum AB with status No longer listed by FDA. The shortage was first posted on Aug 13, 2025.

Shortage details

Status
No longer listed by FDA
Company
Swedish Orphan Biovitrum AB
Package NDC
66658-231-01
Dosage Form
Injection
Presentation
Synagis, Injection, 100 mg/1 mL (NDC 66658-231-01)
Initial Posting
Aug 13, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.